NCT00089050View on ClinicalTrials.gov

Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

May 31, 2004

Study Completion Date

March 31, 2006

Conditions

Leukemia

Interventions

DRUG

cyclosporine

DRUG

gemtuzumab ozogamicin

Trial Locations (1)

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00089050 - Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter